Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes
Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes
Not yet recruiting · NCT07198932 · Registry updated 2025-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes | Insulin Resistance, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, type 2 diabetes mellitus | Not yet recruiting | Not stated | 2025-09-30 | NCT07198932 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yanbing Li | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Hospital of Hebei University | Baoding | China | 8 |
| Beijing Luhe Hospital Affiliated to Capital Medical University | Beijing | China | 2 |
| Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University | Shanghai | China | 1 |
| Shanghai Changzheng Hospital | Shanghai | China | 8 |
| Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University | Hangzhou | China | 3 |
| the First Medical Center of Chinese PLA General Hospital | Beijing | China | 2 |
| Xi'an International Medical Center Hospital | Xi'an | China | 5 |